CV Sciences Shares Outstanding 2011-2019 | CVSI

CV Sciences shares outstanding from 2011 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
CV Sciences Annual Shares Outstanding
(Millions of Shares)
2018 114
2017 80
2016 53
2015 35
2014 32
2013 10
2012 7
2011 7
2010 5
CV Sciences Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 99
Q2 2019 121
Q1 2019 95
Q4 2018 114
Q3 2018 116
Q2 2018 112
Q1 2018 96
Q4 2017 80
Q3 2017 88
Q2 2017 83
Q1 2017 60
Q4 2016 53
Q3 2016 52
Q2 2016 52
Q1 2016 50
Q4 2015 35
Q3 2015 35
Q2 2015 35
Q1 2015 34
Q4 2014 32
Q3 2014 33
Q2 2014 33
Q1 2014 26
Q4 2013 10
Q3 2013 10
Q2 2013 9
Q1 2013 8
Q4 2012 7
Q3 2012 7
Q2 2012 7
Q1 2012
Q4 2011 7
Q3 2011 7
Q2 2011 7
Q1 2011 7
Q4 2010
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.116B $0.048B
CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products. It operates primarily in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is based in Las Vegas, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.924B 38.83
Takeda Pharmaceutical (TAK) Japan $61.813B 9.77
Astellas Pharma (ALPMY) Japan $32.875B 16.42
Eisai (ESALY) Japan $21.999B 42.41
Merck (MKGAF) Germany $16.989B 23.18
Grifols, S.A (GRFS) Spain $15.869B 20.79
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $9.133B 431.17
Catalent (CTLT) United States $9.010B 36.65
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Ionis Pharmaceuticals (IONS) United States $8.358B 16.93
Jazz Pharmaceuticals (JAZZ) Ireland $8.245B 10.53
STADA ARZNEIMI (STDAF) Germany $5.972B 0.00
IPSEN SA ADR (IPSEY) France $5.862B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.282B 16.07
Arrowhead Pharmaceuticals (ARWR) United States $4.270B 64.65
Evotec AG (EVTCY) Germany $4.074B 65.85
United Therapeutics (UTHR) United States $3.920B 0.00
Nektar Therapeutics (NKTR) United States $3.717B 0.00
FibroGen (FGEN) United States $3.647B 107.18
Sage Therapeutics (SAGE) United States $3.525B 0.00
PTC Therapeutics (PTCT) United States $3.200B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.198B 11.77
ChemoCentryx (CCXI) United States $2.396B 0.00
Zogenix (ZGNX) United States $2.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.119B 0.00
Heron Therapeutics (HRTX) United States $2.035B 0.00
Tilray (TLRY) Canada $1.985B 0.00
Xencor (XNCR) United States $1.947B 59.19
Ironwood Pharmaceuticals (IRWD) United States $1.940B 61.85
Pacira Pharmaceuticals (PCRX) United States $1.828B 54.09
USANA Health Sciences (USNA) United States $1.608B 17.16
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.492B 18.13
Theravance Biopharma (TBPH) Cayman Islands $1.487B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.415B 9.65
Endo (ENDP) Ireland $1.343B 2.47
Enanta Pharmaceuticals (ENTA) United States $1.087B 24.71
Portola Pharmaceuticals (PTLA) United States $1.062B 0.00
Karyopharm Therapeutics (KPTI) United States $1.036B 0.00
Dermira (DERM) United States $1.020B 0.00
Aerie Pharmaceuticals (AERI) United States $0.996B 0.00
Akebia Therapeutics (AKBA) United States $0.943B 0.00
Radius Health (RDUS) United States $0.870B 0.00
Collegium Pharmaceutical (COLL) United States $0.702B 0.00
TherapeuticsMD (TXMD) United States $0.673B 0.00
Flexion Therapeutics (FLXN) United States $0.671B 0.00
ImmunoGen (IMGN) United States $0.659B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.547B 0.00
Molecular Templates (MTEM) United States $0.501B 0.00
Translate Bio (TBIO) United States $0.483B 0.00
Ardelyx (ARDX) United States $0.467B 0.00
Organogenesis Holdings (ORGO) United States $0.459B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.437B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.434B 0.00
Innate Pharma SA (IPHYF) France $0.432B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Siga Technologies (SIGA) United States $0.418B 9.56
BioCryst Pharmaceuticals (BCRX) United States $0.417B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.415B 17.91
Catalyst Pharmaceuticals (CPRX) United States $0.410B 49.75
DURECT (DRRX) United States $0.385B 0.00
OptiNose (OPTN) United States $0.371B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
Recro Pharma (REPH) United States $0.361B 0.00
Lannett Co Inc (LCI) United States $0.361B 4.20
Harpoon Therapeutics (HARP) United States $0.360B 0.00
Rafael Holdings (RFL) United States $0.345B 0.00
Indivior (INVVY) United States $0.335B 1.21
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.259B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.258B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.256B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.239B 0.00
MEI Pharma (MEIP) United States $0.237B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
IMV INC (IMV) Canada $0.212B 0.00
Jounce Therapeutics (JNCE) United States $0.210B 2.80
La Jolla Pharmaceutical (LJPC) United States $0.206B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 33.23
Taiwan Liposome (TLC) Taiwan $0.176B 0.00
Xeris Pharmaceuticals (XERS) United States $0.155B 0.00
CannTrust Holdings (CTST) Canada $0.150B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.139B 0.00
Redhill Biopharma (RDHL) Israel $0.131B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Otonomy (OTIC) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.095B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.094B 0.00
PolarityTE (PTE) United States $0.091B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.088B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.73
CTI BioPharma (CTIC) United States $0.074B 0.00
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
AgeX Therapeutics (AGE) United States $0.067B 0.00
Aclaris Therapeutics (ACRS) United States $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.062B 15.39
Nivalis Therapeutics (ALPN) United States $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
IsoRay (ISR) United States $0.056B 0.00
Onconova Therapeutics (ONTX) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Jaguar Animal Health (JAGX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Biomerica (BMRA) United States $0.030B 0.00
PharmAthene (ALT) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
VAXART, INC (VXRT) United States $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Novan (NOVN) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.012B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
Heat Biologics (HTBX) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00